Massimo Degano

Dr. Massimo Degano

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 1996 in Science
Verified
Journal Article
Closed access
PDF file
KGK. Christopher Garcia
K. Christopher Garcia
MDMassimo Degano
Massimo Degano
RSRobyn L. Stanfield
Robyn L. Stanfield
ABAnders Brunmark
Anders Brunmark
MJMichael R. Jackson
Michael R. Jackson
IWIan A. Wilson
Ian A. Wilson
The central event in the cellular immune response to invading microorganisms is the specific recognition of foreign peptides bound to major histocompatibility complex (MHC) molecules by the αβ T cell receptor (TCR). The x-ray structure of the complete extracellular fragment of a glycosylated αβ TCR was determined at 2.5 angstroms, and its orientation bound to a class I MHC-peptide (pMHC) complex was elucidated from crystals of the TCR-pMHC complex. The TCR resembles an antibody in the variable Vα and Vβ domains but deviates in the constant Cα domain and in the interdomain pairing of Cα with Cβ. Four of seven possible asparagine-linked glycosylation sites have ordered carbohydrate moieties, one of which lies in the Cα-Cβ interface. The TCR combining site is relatively flat except for a deep hydrophobic cavity between the hypervariable CDR3s (complementarity-determining regions) of the α and β chains. The 2C TCR covers the class I MHC H-2K b binding groove so that the Vα CDRs 1 and 2 are positioned over the amino-terminal region of the bound dEV8 peptide, the Vβ chain CDRs 1 and 2 are over the carboxyl-terminal region of the peptide, and the Vα and Vβ CDR3s straddle the peptide between the helices around the central position of the peptide.

20 February 1998 in Science
Verified
Journal Article
Closed access
PDF file
KGK. Christopher Garcia
K. Christopher Garcia
MDMassimo Degano
Massimo Degano
LPLarry R. Pease
Larry R. Pease
MHMingdong Huang
Mingdong Huang
PPPer A. Peterson
Per A. Peterson
IWIan A. Wilson
Ian A. Wilson
The T cell receptor (TCR) inherently has dual specificity. T cells must recognize self-antigens in the thymus during maturation and then discriminate between foreign pathogens in the periphery. A molecular basis for this cross-reactivity is elucidated by the crystal structure of the alloreactive 2C TCR bound to self peptide–major histocompatibility complex (pMHC) antigen H-2Kb–dEV8 refined against anisotropic 3.0 angstrom resolution x-ray data. The interface between peptide and TCR exhibits extremely poor shape complementarity, and the TCR β chain complementarity-determining region 3 (CDR3) has minimal interaction with the dEV8 peptide. Large conformational changes in three of the TCR CDR loops are induced upon binding, providing a mechanism of structural plasticity to accommodate a variety of different peptide antigens. Extensive TCR interaction with the pMHC α helices suggests a generalized orientation that is mediated by the Vαdomain of the TCR and rationalizes how TCRs can effectively “scan” different peptides bound within a large, low-affinity MHC structural framework for those that provide the slight additional kinetic stabilization required for signaling.

1 January 2003 in Journal of Molecular Biology
Verified
Journal Article
Closed access
ZMZora Marković-Housley
Zora Marković-Housley
MDMassimo Degano
Massimo Degano
Doriano LambaDoriano Lamba
Doriano Lamba
EREdda von Roepenack-Lahaye
Edda von Roepenack-Lahaye
SCStephan Clemens
Stephan Clemens
HBHeimo Breiteneder
Heimo Breiteneder

1 March 2000 in Immunity
Verified
Journal Article
Closed access
MDMassimo Degano
Massimo Degano
KGK.CHristopher Garcia
K.CHristopher Garcia
Vasso ApostolopoulosVasso Apostolopoulos
Vasso Apostolopoulos
MRMarkus G Rudolph
Markus G Rudolph
LTLuc Teyton
Luc Teyton
IWIan A Wilson
Ian A Wilson

4 January 1999 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
EGEthan P. Grant
Ethan P. Grant
MDMassimo Degano
Massimo Degano
JRJean-Pierre Rosat
Jean-Pierre Rosat
SSSteffen Stenger
Steffen Stenger
RMRobert Modlin
Robert Modlin
MBMichael B. Brenner
Michael B. Brenner
The T cell antigen receptor (TCR) mediates recognition of peptide antigens bound in the groove of major histocompatibility complex (MHC) molecules. This dual recognition is mediated by the complementarity-determining residue (CDR) loops of the α and β chains of a single TCR which contact exposed residues of the peptide antigen and amino acids along the MHC α helices. The recent description of T cells that recognize hydrophobic microbial lipid antigens has challenged immunologists to explain, in molecular terms, the nature of this interaction. Structural studies on the murine CD1d1 molecule revealed an electrostatically neutral putative antigen-binding groove beneath the CD1 α helices. Here, we demonstrate that α/β TCRs, when transferred into TCR-deficient recipient cells, confer specificity for both the foreign lipid antigen and CD1 isoform. Sequence analysis of a panel of CD1-restricted, lipid-specific TCRs reveals the incorporation of template-independent N nucleotides that encode diverse sequences and frequent charged basic residues at the V(D)J junctions. These sequences permit a model for recognition in which the TCR CDR3 loops containing charged residues project between the CD1 α helices, contacting the lipid antigen hydrophilic head moieties as well as adjacent CD1 residues in a manner that explains antigen specificity and CD1 restriction.

31 October 2014 in mBio
Verified
Journal Article
Open access
PDF file
PMPaolo Miotto
Paolo Miotto
ACAndrea M Cabibbe
Andrea M Cabibbe
SFSilke Feuerriegel
Silke Feuerriegel
NCNicola Casali
Nicola Casali
FDFrancis Drobniewski
Francis Drobniewski
DCDaniela M Cirillo
Daniela M Cirillo
Pyrazinamide (PZA) is a prodrug that is converted to pyrazinoic acid by the enzyme pyrazinamidase, encoded by the pncA gene in Mycobacterium tuberculosis . Molecular identification of mutations in pncA offers the potential for rapid detection of pyrazinamide resistance (PZA r ). However, the genetic variants are highly variable and scattered over the full length of pncA , complicating the development of a molecular test. We performed a large multicenter study assessing pncA sequence variations in 1,950 clinical isolates, including 1,142 multidrug-resistant (MDR) strains and 483 fully susceptible strains. The results of pncA sequencing were correlated with phenotype, enzymatic activity, and structural and phylogenetic data. We identified 280 genetic variants which were divided into four classes: (i) very high confidence resistance mutations that were found only in PZA r strains (85%), (ii) high-confidence resistance mutations found in more than 70% of PZA r strains, (iii) mutations with an unclear role found in less than 70% of PZA r strains, and (iv) mutations not associated with phenotypic resistance (10%). Any future molecular diagnostic assay should be able to target and identify at least the very high and high-confidence genetic variant markers of PZA r ; the diagnostic accuracy of such an assay would be in the range of 89.5 to 98.8%. IMPORTANCE Conventional phenotypic testing for pyrazinamide resistance in Mycobacterium tuberculosis is technically challenging and often unreliable. The development of a molecular assay for detecting pyrazinamide resistance would be a breakthrough, directly overcoming both the limitations of conventional testing and its related biosafety issues. Although the main mechanism of pyrazinamide resistance involves mutations inactivating the pncA enzyme, the highly diverse genetic variants scattered over the full length of the pncA gene and the lack of a reliable phenotypic gold standard hamper the development of molecular diagnostic assays. By analyzing a large number of strains collected worldwide, we have classified the different genetic variants based on their predictive value for resistance which should lead to more rapid diagnostic tests. This would assist clinicians in improving treatment regimens for patients.